版本:
中国

BRIEF-UCB and Amgen announce findings from the FRAME study

Sept 19UCB SA :

* UCB and Amgen reported on Sunday findings from the FRAME study

* Findings show that the investigational agent romosozumab significantly reduced the incidence of new vertebral fractures in postmenopausal women with osteoporosis through 12 and 24 months, meeting the study's co-primary endpoints

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐